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Am. J. Physiol. 264 (Heart Circ. Physiol. 33): Hl896-H1906, 1993.-We examined the relationship between transsarcolemmal cation gradients and hypercontracture of cardiac myocytes in ischemia and reperfusion using adult rat ventricular myocytes superfused with buffer mimicking normal or ischemic extracellular fluid. Contractile performance of electrically stimulated cells was recorded by an optical video system simultaneously with measurements of intracellular Ca2+ concentration ( [Ca2+]i ) using fura-or intracellular pH (pHi) using 2',7'-bis(Z-carboxyethyl)-5(6)-carboxyfluorescein.
While cells were exposed to simulated ischemia buffer, the transsarcolemma1 H+ gradient was abolished, [Ca2+]i transient stopped, and twitch contraction of myocytes ceased. Upon reperfusion with normal buffer, H+ gradient was quickly restored, Ca2+ transients restarted with transient increase in systolic Ca2+, and twitch contraction restarted with development of hypercontracture, which continued after [Ca2+]i returned to preischemic level even in the presence of near-normal concentrations of high-energy phosphates. When the transsarcolemmal proton, Na+, and Ca2+ gradients were altered so that Na+ entry via Na+-H+ exchange and Ca2+ entry via Ca2+-Na+ exchange were made less favorable, the transient systolic overshoot of Ca2+ at reperfusion and development of hypercontracture was largely avoided. These results suggest that Na+ and then Ca2+ entry via the Na+-H+ and Na+-Ca2+ exchangers, respectively, probably contribute to the increase in [Ca2+]i and hypercontracture of myocytes at time of reperfusion in this model.
fura-2;
2',7'-bis(Z-carboxyethyl)-5(6)-carboxyfluorescein; ischemic injury ALTHOUGH REPERFUSION of ischemic myocardium is an indispensable therapy of ischemic heart diseases, it is widely acknowledged that reperfusion causes detrimental effects on ischemic heart tissue by itself (7, 30, 32) . In vivo manifestations of "reperfusion injury" are 1) reperfusion arrhythmias, 2) myocardial stunning, and 3) possible exacerbation of necrosis in potentially viable cells in the ischemic region. Despite investigations in diverse model systems from many laboratories, the mechanisms of reperfusion injury remain complex and uncertain (1, 35) . This is due in part to the heterogeneous composition of heart tissue. Injury might be caused by direct toxic effects to myocytes of reperfusion or, through vascular injury at reperfusion, manifest as no reflow or extracellular edema (32) . Accumulation of Ca2+ in myocardial tissue is a key element of myocyte injury during reperfusion (35) , and there is little doubt that excessive Ca2+ accumulation can be the proximate cause of irreversible cellular injury under some, but not all, ischemia-reperfusion conditions (38, 41) . However, the interaction between and sequence of events in changes in cytosolic Ca2+ activity, intracellular Ca2+ concentration ([ Ca2+] ;), cytosolic Na+ activity, intracellular Na+ concentration ([ Na+] ;), or proton activity (intracellular pH, or pHi) or even changes in the absolute concentration of intracellular highenergy phosphates (HEPs) remain incompletely resolved (34, 35) .
In this study, we used a model of isolated myocytes exposed to simulated ischemic condition.
This singlecell model of ischemia, similar to that of Ferrier et al. (14) and Koyama et al. (22) , enabled us to evaluate the direct effect of ischemia on cardiac myocytes by excluding diffusion barriers and possible contribution of vascular elements and by avoiding mechanical injury by adjacent cells (17) . This model also permits us concurrent assessment of a myocyte's contractile performance and intracellular ion activity using fluorescence dye techniques (5). We specifically sought to determine how changes in the intracellular activities of Na+ and H+ could modify [Ca2+] i and contractile function during ischemia and subsequent reperfusion. We tested the hypothesis that the transsarcolemmal Na+ gradient plays a pivotal role in initiating a sequence of events that could lead to irreversible cell injury. In a single-cell model, it is also possible to define a unique end point of irreversible reperfusion injury: cell shortening to 60% of its initial resting length, or "hypercontracture" (17) . An experimental model that permits measurement of intracellular ion activities, cellular energetics, and contractile activity is likely to provide results that would allow a more integrated approach to the complex matrix of interacting cellular events during ischemia and reperfusion and may possibly be of greater relevance to events in vivo.
METHODS

Myocyte Isolation
Ventricular myocytes were isolated from adult rat hearts by methods described previously (5) with minor modifications. Briefly, female Sprague-Dawley rats (250-300 g, Charles River) were deeply anesthetized with ether. Hearts were removed and were perfused for 25 min with nominally Ca2+-free KrebsHenseleit bicarbonate (KHB) buffer containing 118 mM Na+, 3.2 mM K+, and 0.05% collagenase. Ventricles were minced and incubated for 15 min in KHB buffer with 0.05% collagenase followed by the addition of 1 vol of KHB buffer with 1.25 mM Ca2+. Dissociation buffers were at 37°C and pH 7.4. Myocytes were released by trituration, filtered through Nytex mesh (100 pm), and sedimented through 2% bovine serum albumin in KHB buffer (1.25 mM Ca2+). Myocytes were suspended in control buffer (Table 1 ). All the buffers used for isolation were bubbled with 95% 02-5% CO,. In brief, myocytes were loaded with fura-by incubation of a 2-ml suspension of myocytes (50,000 cells/ml) for 5 min at 25°C with fura-2/AM (2 PM) in dimethyl sulfoxide. A glass cover slip with fura-2-loaded myocytes attached was placed in a water-jacketed chamber (37°C) on the stage of an inverted epifluorescence microscope (Nikon Diaphot). Phase-contrast illumination (700-nm wavelength) was passed through an adjustable aperture, and the image from a single myocyte was directed to a CCD video camera (Pulnix TM 540/560) and monitored on a television monitor (Panasonic WV 5470) throughout the experiment. Cell length was measured on the monitor. The image was also directed to a motion detector (Crescent Electronics, Sandy, UT), and amplitude of motion of one end of the cell during tonic or phasic contraction was recorded on a chart recorder (Gould 2200, Cleveland, OH) (6). Cells were also exposed concurrently to illumination from a Spex CM2 dual-excitation spectrofluorimeter (Spex Industries, Edison, NJ) at 340 and 380 nm. Fura-emission fluorescence collected from a single myocyte by an adjustable aperture was passed through a band-pass filter (500 rf: 10 nm) and detected by a photomultiplier tube (Hamamatsu R268UH). Phase-contrast illumination and fura-emission fluorescence were separated by a dichroic mirror (600-nm cutoff). Cells were stimulated to contract by a Grass S88 stimulator and a platinum wire field electrode. Stimulation was at 25% above threshold during the initial control buffers reperfusion, with a 2-ms square-wave pulse.
[Ca2+]i was calibrated in situ in each individual myocyte using a procedure previously described and validated in this laboratory (5). Briefly, at the end of the experimental protocol, minimum fura-fluorescence was determined by exposing cells to zero Ca2+ buffer containing 1 mM ethylene glycol-bis@-aminoethyl ether) -N,N,N',N'-tetraacetic acid (EGTA), 5 mM pyruvate, and 10 PM ionomycin. Maximum fura-fluorescence was determined with 1 mM La"+ substituting for EGTA. 
Protocol and Superfusion Buffers
The basic protocol for simulated ischemia-reperfusion experiments was in accordance with the following sequence: superfusion with the control perfusion buffer for 5 min, followed by superfusion with the simulated ischemia buffer containing cyanide, 2-deoxyglucose, excess K+, and lactate at pH 6.50 (Table  1) for 5 min and reperfusion with the control buffer for 5 min, or with one of several experimental reperfusion buffers for 4 min, followed by control buffer for 5 min. All experiments (with one exception noted below) followed this protocol. Buffers were equilibrated with room air. To minimize photobleaching and possible toxic effect of ultraviolet light, cells were exposed to periods of continuous excitation light for only 10-s intervals with 3 ms/data sampling at 340-and 380-nm excitation, with 9-ms intervals for acquisition of emission signals at the two excitation wavelengths for ratio spectroscopy. An excitation spectrum of the fura-signal between 300 and 400 nm monitored at 500 t IO-nm emission was performed before and after experiments to assess dye leakage. Experiments in which cell fura-fluorescence at 360 nm (isosbestic point) was reduced by ~50% at the end of the experiment were rejected from the analysis. To minimize the effect of changes in the intracellular milieu that would influence the fura-emission ratio, cells were calibrated by an in situ calibration technique described above (5). An explicit description of the contents of the normal physiological "control" buffer, the simulated ischemia buffer, and other buffers modified to vary the transsarcolemmal pH, Na+, and Ca2+ gradients during simulated ischemia and reperfusion is given in ischemia and reperfusion buffers were reduced to 40 and 60 mM, respectively. Choline chloride (70 mM) was added to these buffers to maintain constant ionic strength and osmolarity. For superfusion with 0 mM [Ca"+], the ischemia and reperfusion buffer contained 1 mM EGTA instead of CaC12. All cells attached to cover slips were superfused continuously with buffer at 1 ml/min. The volume of the chamber was 0.8-1.0 ml, so that complete superfusate change occurred in 51 min. Onset of the effect of buffer change occurred typically within 15-30 s. Superfusion of cells with the buffer simulating several elements of ischemia are referred to herein as perfusion with ischemia buffer. Superfusion with control buffer after ischemia buffer will be referred to as reperfusion, by analogy with intact organ ischemia-reperfusion protocols.
HEP Compound Assay
Cellular content of HEP compounds (creatine phosphate and adenine nucleotides) was determined by high-performance liquid chromatography (HPLC). Freshly isolated myocytes were suspended in control perfusion buffer (600,000 cells/ml). After incubation in experimental buffers in protocols identical to those for contractility experiments, the suspended cells were rapidly centrifuged. HEPs were extracted with 0.3 M perchloric acid and neutralized with 5 M K,HPO,.
After centrifugation, the supernatant was filtered through a 0.45pm filter and HEPs were assayed by HPLC (Waters, Milford, MA). Protein content of cells was assayed by the Lowry method (27) . HEP samples were run on an anion-exchange column (Radial-PAK 8PSAXl0, Waters) with a mobile phase of H3P04-KH2P04 and eluted with a linear gradient. HEPs were detected by an ultraviolet detector at 210 nm and calibrated by analysis of authentic HEP standards.
Statistics
Results are expressed as means t SE. Means between groups were compared by analysis of variance followed by Scheffe's F test. Distribution between groups was compared by contingency table analysis.
Reagents and Chemicals
Collagenase (class II) was purchased from Worthington. Fura-2/AM and BCECF were from Molecular Probes (Eugene, OR). Reagents used for HEP determinants were all of HPLC grade and purchased from Fisher (Medford, MA). All other chemicals were reagent grade or better.
RESULTS [Ca'+]i in Isolated Myocytes
[ Ca2+] i and contractility were measured simultaneously in isolated adult myocytes loaded with the fluorescent dye, fura-2, under both control conditions and conditions of simulated ischemia and reperfusion. Although we attempted in situ calibration after the simulated ischemia-reperfusion experiments, unlike control cells these cells did not tolerate the calibration procedure and developed hypercontracture after exposure to ionophores and La 3+ We therefore estimated relative . Figure 2 illustrates the data gathered from 10 cells subjected to simulated ischemia and reperfusion.
During the control perfusion of the ischemia-reperfusion protocol, both systolic and end-diastolic .75 ' , , , To determine the significance of alterations in cytosolit pH, individual myocytes were exposed to ischemia buffer. This produced a profound decline in cytosolic pH from a control value of 7.16 to pH 6.49 after 4 min of exposure (Fig. 3) . Upon washout of ischemia buffer the pH recovered to 7.04 within 4 min, demonstrating that [H+] gradients could be restored even after this severe degree of intracellular acidosis. This series of experiments was repeated in additional cells in which calibration of the cytosolic pH in absolute terms was not reliable because of morphological changes during the calibration procedure. Qualitatively similar results were obtained. To elucidate the effect of changes in cytosolic pH on [ Ca2+]i during reperfusion, we reperfused fura-2-loaded myocytes that had been exposed to simulated ischemia buffer (pH 6.50) with reperfusion buffer of pH 6.8 instead of pH 7.4 (Fig. 4) In addition to changes in the transsarcolemmal H+ gradient, the Na+ gradient across the sarcolemma would also probably affect [Ca2+]i. We therefore examined the effect of low Na+ buffers (see Table 1 ) during the ischemic and reperfusion portions of the protocol. As illustrated in Fig. 5 , perfusion with control buffer was followed by perfusion with the standard ischemia buffer (pH 6.50) for 5 min followed by a 5-min perfusion with a low Na+ ischemia buffer (pH 6.50) and finally, reperfusion for 5 min with low Na+ reperfusion buffer (pH 7.4). Thus, unlike other experiments, in this experiment cells were in ischemia buffer for 10 min. In fura-2-loaded myocytes exposed to this sequence of buffers, the with low Na+ reperfusion buffer, [ Ca'+]; transients recovered after 30 s. As was the case with reperfusion with control buffer at pH 6.8 shown in Fig. 4 , the overshoot of the [Ca'+]i transient was not observed, in marked contrast to the overshoot seen with reperfusion with physiological buffers at pH 7.4. The amplitude of the [Ca'+]; transient also decreased to a level below control conditions after 4 min of reperfusion. If cells were exposed to ischemia buffer for 5 min and then directly switched to 70 mM Na+ reperfusion buffer, they immediately developed hypercontracture (data not shown). To determine the contribution of extracellular Ca2+ to the observed changes in [Ca2+]; during ischemia and reperfusion we also examined the effect of very low Ca2+ buffers. Fura-2-loaded myocytes were perfused initially with the physiological control buffer as in the protocols described above, exposed to 0 mM Figure 6 illustrates the changes in the 340-to-380 nm fluorescence ratio during those experiments.
[ Ca2+] i transients ceased after perfusion with zero Ca2+ ischemia buffer, and the mean fluorescence ratio under these conditions was significantly lower than that observed during perfusion with 1 mM Ca2+ i schemia buffer.
[ Ca2+] i transients did not reappear upon reperfusion with zero Ca2+ control buffer at pH 7.4, but they did reappear upon perfusion with the regular control buffer (1 mM Ca2+) within 2 min. There was no initial overshoot or sustained augmentation o f either the tolic and diastolic values of S ubsequent amplitude or sysCa2+ transients .
Contractile Function of Isolated Ventricular During Ischemia and Reperfusion
Myocytes
In each of the protocols described above, contractile amplitude was recorded continuously and simultaneously while fura-or BCECF fluorescence signals were acquired. Figure 7A shows a typical recording of myocyte contractile amplitude in a myocyte stimulated at 2.0 Hz and perfused initially with physiological control buffer and then exposed to simulated ischemia buffer followed by reperfusion with a standard control buffer. Immedi- ately after perfusion with the ischemia buffer (pH 6.50), there was transient augmentation of contractile amplitude followed by cessation of contraction within 2 min. The length of the quiescent cell increased slightly during perfusion with ischemia buffer. After reperfusion with control perfusion buffer, cell contraction was restored within 30 s, concurrent with the restoration of [Ca2+]i transients. The amplitude of contraction was typically two to three times greater than amplitude of contraction during the initial preischemic control buffer perfusion. Amplitude of contraction subsequently declined to less than control amplitude. Hypercontracture developed during the time that amplitude was declining, with shortening of the diastolic length of the cell until the cell reached a square form. This excessive shortening of the diastolic length of the cell, or hypercontracture, was observed in 85% of cells after metabolic inhibition with ischemia buffer followed by reperfusion with control buffer (Table  2 ) and occurred regardless of whether cells were loaded with fura-or BCECF or were exposed to periodic ultraviolet excitation light.
The contractile performance of cells in bicarbonatecontaining buffer was also examined. The composition of the bicarbonate buffers was identical to that for the preceding experiments except that HEPES was deleted, 18 mM NaHC03 was added, and buffers were equilibrated with 5% C02. The pH of the buffer determined by a pH indicator did not change significantly during its passage through the chamber. After 5 min of simulated ischemia, all cells in NaHCOs buffer developed hypercontracture when subjected to reperfusion at pH 7.4 (Table 2 ), similar to the pattern for cells in HEPES buffer.
To examine the effect of a low pH reperfusion buffer on contractility and diastolic cell shortening, myocytes superfused with ischemia buffer for 5 min were then reperfused with control buffer at pH 6.8 instead of pH 7.4 (Fig.  7B) . As observed previously, contraction stopped during perfusion with simulated ischemia buffer but recovered rapidly after reperfusion with buffer at pH 6.8. The twitch amplitude increased gradually to 75% of that seen with control buffer perfusion within 2 min and remained at this slightly diminished level thereafter. The transient augmentation in twitch amplitude followed by hypercontracture observed with reperfusion at pH 7.4 was not observed with reperfusion at pH 6.8. If myocytes were exposed to normal physiological buffer at pH 7.4 after initial reperfusion with physiological buffer at pH 6.8 for 5 min, it was uncommon for these cells to develop hypercontracture.
Ischemia, Reperfusion, and Myocyte Hypercontracture Excessive diastolic shortening of myocytes to ~60% of the cell's original length during diastole (hypercontracture) was used as an indicator of irreversible cell injury. In no case did we observe a cell that had undergone diastolic shortening of ~60% during reperfusion subsequently lengthen (relax) despite observing over 200 cells for at least 45 min. Cells exposed to ischemia buffer for 5 min and then control buffer for 5 min were observed for uptake of trypan blue. 100% of rodshaped cells in control buffer excluded trypan blue. The incidence of hypercontracture after simulated ischemia and reperfusion is summarized in Table 2 . Myocytes studied under a variety of ischemia-reperfusion protocols were divided into three groups based on the ratio of preischemic cell length to postreperfusion length. The "normal" group comprised cells maintaining >90% of their preischemic diastolic The "moderate contracture C 71 ell length (reversible 1 njury). group contained cell .S whose diastolic cell length was >60% and <90% of control cell length. Based on the absence of any example of a return to a preischemic diastolic cell length, we judge these moderately contracted cells to probably be irreversibly injured. Cells shortened to ~60% of initial length were 6.7 6.7* termed hypercontracted. Therefore, using diastolic shortening to ~60% of control length as an index of irreversible injury, we studied the effect of varying the transsarcolemmal pH, Ca2+, and Na+ gradients during simulated reperfusion on myocyte contractile function and the development of hypercontracture. Reperfusion at pH 6.8. Eighty-six percent of myocytes perfused with simulated ischemia buffer for 5 min followed by reperfusion with normal control buffer at physiological pH (7.4) developed hypercontracture ( Table 2) .
In marked contrast, if cells exposed to simulated ischemia buffer were reperfused initially with low pH control buffer (pH 6.8) for 5 min followed by perfusion with pH 7.4 buffer for 5 min, only 9.5% of cells developed hypercontracture.
Reperfusion with low Na+ (70 mM) buffer or amiloride.
To evaluate the effect of varying the sarcolemmal Na+ gradient on myocyte contracture, we reperfused myocytes with low Na+ buffer ([Na+] = 70 mM). When the cells were reperfused with low [Na+] buffer directly after simulated ischemia buffer (140 mM Na+), cells developed blebs and changed into hypercontracted round forms. This may have occurred because, upon change in perfusate composition at time of reperfusion, it would take several seconds to lower the effective [Na+] at the external sarcolemmal surface. Cells were therefore reperfused with a low [Na+] (70 mM) ischemia buffer for 5 min after regular ischemia buffer and reperfused with a low [Na+] (70 mM) control buffer followed by control buffer ([Na+] = 140 mM). This protocol produced a 19% incidence of hypercontracture (Table 2) . To determine whether blockade of sarcolemmal Na+-H+ exchanger would prevent the marked degree of cell shortening observed with 140 mM Na+ control buffer, myocytes were exposed to 100 pM amiloride immediately before and during simulated reperfusion. Amiloride effectively prevented any hypercontracture of cells reperfused with 140 mM Na+ and demonstrated no consistent positive or negative inotropic effect in this protocol. Thus hypercontracture of myocytes was prevented by 100 PM amiloride-containing buffers as well as low [ Na+] buffer (Table 2) . Na+ channel blockade. Na+ entry via the Na+ channel during simulated ischemia may contribute to Na+ overload if the action potential persists or if Na+ channels remain in an open state. To test this hypothesis, ischemia buffer was supplemented with 15 PM tetrodotoxin (TTX). When cells were superfused with control buffer after 5 min ischemia and TTX, no cells developed hypercontracture, and all cells began contracting again but with diminished amplitude (Table 2 ).
Reperfusion with low Ca2+ buffer. The effect of zero Ca2+ reperfusion on cell shortening and contractile function was also examined. Reperfusion with 0 mM [ Ca2+] -1 mM EGTA control buffer directly after simulated ischemia induced bleb formation and rapid rounding up of myocytes. As is the case with low extracellular Na+ reperfusion, cells were perfused with modified ischemia buffer containing 0 mM [Ca2+] -1 mM EGTA ischemia buffer after 5 min of metabolic inhibition with the usual 1 mM Ca2+ ischemia buffer and then reperfused with 0 mM [ Ca2+] -1 mM EGTA control buffer followed by regular control buffer. This zero Ca2+ ischemia-reperfusion protocol abolished [ Ca2+]i overshoot and significantly reduced, but did not abolish, hypercontracture of myocytes, as indicated in Table 2 .
Hypercontracture and duration of ischemic injury. The effect of duration of ischemic perfusion on myocyte viability as determined by the development of hypercontracture was also examined (Table 3) . Cells were superfused for graded periods with simulated ischemia buffer. When myocytes were reperfused with control buffer at pH 7.4, most of the cells developed hypercontracture at any duration of ischemic perfusion lasting >5 min. Reperfusion with buffer at pH 6.8 prevented the cells from developing hypercontracture in every experiment from 5 to 20 min of ischemia. III, cell length < 60% of original (hypercontracture). * P < 0.002 vs. ischemia duration 0 min using contingency table analysis.
Effect of K+ and Lactate
To determine the effect of elevation in superfusate [K+] alone on cell contractile properties, cells were superfused with control buffer for 5 min, with buffer containing 12 mM KC1 for 10 min and then with control buffer for 5 min. Amplitude of contraction declined for all cells during 12 mM KC1 superfusion (n = 5), and two cells ceased contracting.
During reperfusion with control buffer, amplitude of contraction was, on average, moderately depressed. Resting cell length was entirely unchanged comparing length in control buffer, 12 mM KCl, and at end of reperfusion.
The effect of an additional component of ischemia buffer, 20 mM lactate (pH 7.4), was studied in isolation using an identical protocol. Lactate only produced a decline in amplitude of contraction to 28 t 5% of control. With washout, amplitude recovered to 80 t 8% of control by 5 min. There was no change in resting cell length during or after lactate superfusion.
HEP Compounds and Simulated Ischemic Perfusion in Isolated Myocytes
HEP compound content of myocytes is an important determinant of contractile state and probably of cell viability. We measured HEP content in isolated adult rat myocytes by HPLC (Table 4) . In control myocytes, superfused with physiological buffer at pH 7.4, the ATP and ADP contents were 22.6 t 1.7 and 3.6 t 0.3 nmol/mg protein, respectively, and the ATP-to-ADP ratio was 6.5 + 0.4. Creatine phosphate content was 29.6 t 1.0 -nmol/mg protein. When myocytes were exposed to control buffer perfusion followed by simulated ischemia buffer for 5 min, the content of ATP and ADP did not decrease significantly but did decrease significantly if the duration of simulated ischemia was lengthened to 10 min. The ratio of ATP to ADP and [creatine phosphate] were significantly decreased by 5 min, however. After resuspension in pH 7.4 control buffer after 5 min of ischemia buffer, the ATP and ADP contents did not change and the ATP-to-ADP ratio and the creatine phosphate content returned toward normal. One important difference between myocytes being examined on a cover slip for [Ca2+]i or pHi and contractility measurements and myocytes in suspension used for determination of HEP content is that myocytes on a cover slip stimulated at 2 Hz typically contract for the initial l-2 min in ischemia buffer before becoming quiescent for the subsequent 3-4 min, whereas myocytes in suspension are not stimulated and are presumed to be relatively quiescent throughout the protocol. Thus the data from cells exposed to the simulated ischemia protocol at 5 min probably overestimates HEPs compared with stimulated cells on a cover slip at 5 min. HEPs at 10 min are likely to be underestimated but serve to bracket the value for cells on a cover slip. The absolute values of HEPs and the ATP-to-ADP ratio in control cells demonstrates that these myocytes have good energy stores initially and from this perspective serve as an adequate model for studies of ischemia and reperfusion.
DISCUSSION
These studies help to define the interrelationship among irreversible myocyte injury at reperfusion and several important determinants of cell function and viability, including the transsarcolemmal Ca2+, H+, and Na+ gradients and cellular HEP content. There are four major observations in this report.
The first observation is the triphasic change in [Ca2+]i during simulated ischemia followed by reperfusion. Under our experimental conditions, the diastolic [ Ca2+]i is 72 nM and peak systolic [Ca2+]i is 809 nM for a normally contracting adult rat myocyte at 37°C stimulated at 2 Hz. During simulated ischemia, the Ca2+ fluorescence ratio of the quiescent cell is maintained at a value between values of diastolic and systolic found under control conditions. Thus, during 5 min of simulated ischemia with 1 mM extracellular [Ca2+], there is no major increase in cytosolic Ca2+ concentration. Interestingly, upon reperfusion, when the ischemia buffer is washed out with control buffer, there is an immediate and transient increase in systolic Ca2+ to -200% of the control value, which was followed by returning to normal or moderately declining levels of diastolic and systolic Ca2+.
The second finding is the dissociation of contractile amplitude from [ Ca2+] i upon reperfusion after simulated ischemia. Cell contractility, which stops during simulated ischemia for 5 min, resumes at reperfusion with a transient augmentation in the amplitude that is associated with a transient increase in systolic Ca2+. We consistently observed the subsequent development of contracture (failure of diastolic relaxation) that occurred despite the presence of normal or moderately declining levels of diastolic and systolic Ca 2+. Importantly, contracture developed at a time when neither the concentration of ATP nor the ATP-to-ADP ratio were significantly depressed and the concentration of creatine phosphate was only modestly decreased, at least when studied in quiescent myocytes in suspension exposed to identical buffers for the same duration of time. Thus contracture of a myocyte can occur in the presence of normal or near-normal HEP concentrations and in the presence of a cytosolic Ca2+ activity that has returned to normal after a transient, but probably important, elevation.
A third observation is that, during simulated ischemia, pHi rapidly falls, abolishing the transsarcolemmal H+ gradient. Upon reperfusion, pHi returns to control values within 4 min if reperfusion is with physiological buffer at pH 7.4, and yet contractile amplitude remains depressed, although at a significantly decreased cell length. Thus the depression in contractility seen after 4 min of reperfusion cannot be ascribed to persistent intracellular acidosis.
The that Na+ accumulation and hence Ca2+ accumulation was primarily due to Na+-H+ and Na+-Ca2+ exchange. Na+ accumulation was shown to be due to increased entry rather than decreased extrusion. Their observations in an intact heart, using techniques distinct from those in the present study, are entirely consistent with and complementary to our observation in single cells subjected to simulated ischemia. Moreover, Pike et al. (36) found that in intact perfused ferret heart studied by NMR there is evidence for [Na+]i remaining elevated briefly upon reperfusion, setting up gradients that could produce a brief overshoot in [Ca2+]i. Thus evidence from a number of experimental approaches is converging to support the pivotal role of Na+ entry after hypoxia or ischemia. Blockade of Na+ channel-dependent Na+ entry with TTX ameliorates cells injury (Table 2) . This observation also is consistent with the Na+-overload hypothesis. However, the present data do not permit one to entirely discount the alternate explanation that TTX is halting the action potential during ischemia and thereby directly limiting Ca2+ entry during depolarization. Because diastolic Ca2+ increases only slightly during ischemia (Fig. 2) , we view the latter explanation of the TTX effect less likely.
It would be desirable to demonstrate directly in a single myocyte that [Na+]i increases at time of reperfusion. To date, this has not been feasible because of shifts in spectral properties of Na+-sensitive dyes in the pH 6.50-7.00 range. However, there can be little doubt that [Na+]i does increase at the time of reperfusion in our model system. We have previously reported that 24Na+ content increases after hypoxia-reoxygenation in cultured myocytes (29, 31) , and others have reported an increase after hypoxia-reoxygenation in intact heart (2) and after ischemia-reperfusion in the intact heart (35, 43) . Na+ influx via Na+-H+ exchange is the most likely mechanism for a probable increase in intracellular Na+ and subsequent Ca2+ overload by Na+-Ca2+ exchange. Although the amiloride data and low pH perfusion data support this postulate, we cannot exclude direct inhibition of Na+-Ca2+ exchange by low pH or amiloride.
Mechanism of Hypercontracture
Why would a brief increase in systolic [Ca2+]; to about two times control values be associated with failure of diastolic relaxation and development of hypercontracture? We have observed nearly this degree of increase in [Ca2+]; during inotropic stimulation of myocytes, with no dire sequelae. The present data do not permit a definitive resolution of this paradox but suggest some possible explanations. First, [ Ca2+]; estimated with the techniques used here report [Ca2+]i very rapidly (9-ms sampling) but do not account for any buffering of Ca2+ that may be entering the cell and thus would be unavailable for binding fura-2, nor do they account for possible spatial gradients within the cell. Therefore [Ca"+]; measurements may be grossly underestimating the total magnitude of Ca2+ influx and may miss spatially localized very high [Ca"+].
It remains uncertain how reperfusion-associated Ca2+ influx early after 5 min of simulated ischemia commits the cell to development of contracture and probable cell death even after The current data do permit at least a provisional conclusion that the Ca2+ influx associated with reperfusion does not appear to produce cell death by causing mitochondrial failure in this model. During reperfusion HEPs are resynthesized.
What is the mechanism of cellular injury in this model of ischemia and reperfusion if it is not solely due to HEP depletion? We speculate that the transient overshoot in systolic [Ca2+]i and/or masked Ca2+ accumulation by organelles and binding sites may activate phospholipases or proteases that could increase membrane permeability and produce inevitable irreversible injury, even though [ Ca2+]; can be at least transiently restored to its normal range. Alternatively, arrest and then resumption of oxidative metabolism might favor generation of oxygen-derived free radicals, which have been demonstrated to produce reperfusion injury in vivo (30) . We have previously reported that in an hypoxia-reoxygenation cultured myocyte model system, free radical scavengers can limit "reperfusion" injury, suggesting that a system such as this that is devoid of leukocytes and endothelial elements can still generate oxygen-derived free radicals (29) .
Isolated Single Myocyte Model
The simplified model of ischemic injury used for these experiments deserves comment. We used the isolated adult rat ventricular myocyte model, in which contractile function in single cells could be monitored simultaneously with acquisition of fluorescence emission spectra that varied in proportion to change in intracellular Ca2+ or H+ activities and a buffer system to simulate ischemia and reperfusion. Of note, the absolute values for [Ca2+]; (systolic and diastolic) under control conditions and the percentage change under simulated ischemic conditions are similar to those of intact heart by Kihara et al. (20) using a different intracellular indicator of [ Ca2+]+ aequorin, in the intact ferret heart and are comparable to results of Lee et al. (25) using indo-l in the intact rabbit heart. Single-cell models for the study of mechanisms of ischemic injury are well established and have been widely used for many years (10, 12, 19, 22, 24, 26, 29, 37, 41) . Most previous studies have taken a more limited approach than in the current investigation, examining cells subjected to hypoxia (42) or to metabolic inhibition, most commonly with cyanide and 2-deoxyglucose, as were used in the current investigation (11). 2-Deoxyglucose, an irreversible inhibitor of glycolysis, has little effect by itself on most single-cell model systems as long as aerobic metabolism could be maintained.
Cyanide specifically and reversibly inhibits mitochondrial electron transport in a well-characterized manner similar to removal of molecular oxygen (11) . The present study extends the metabolic inhibition model of ischemia to include concentrations of important molecules found in the interstitium of reversiblv ischemic heart and is similar to the model of Kovama
